Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors
Clinical trial NCT03102320 · COMPLETED
Trial details
- NCT number
- NCT03102320
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-26
- Primary completion
- 2020-09-16
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.